Literature DB >> 2985788

T cell early activation antigens expressed by peripheral lymphocytes in Crohn's disease.

S Fais, F Pallone, O Squarcia, M Boirivant, P Pozzilli.   

Abstract

We studied the expression of early activation antigens (4F2, transferrin receptor, IL-2 receptor) on peripheral lymphocytes (PBL) of patients with Crohn's Disease. We have found that the proportion of PBL expressing these antigens was significantly higher in patients than in controls. The expression of the 4F2 antigen was more pronounced than that of other activation antigens directly involved in promoting cell growth (e.g. transferrin receptor, IL-2 receptor). These results indicate that CD patients have an increased number of T cells in a very early phase of activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985788

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  6 in total

1.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

5.  Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation.

Authors:  L Biancone; M Boirivant; S Fais; G L Ricci; R Paganelli; F Pallone
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 6.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.